Detalhe da pesquisa
1.
Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study.
J Am Soc Nephrol
; 33(6): 1193-1207, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35354600
2.
Rituximab in childhood steroid-sensitive nephrotic syndrome: are multiple subsequent courses safe and effective?
Arch Dis Child
; 2020 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33177054